Paper Details

  1. Home
  2. Paper Details

Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.

Author: DubinskyMarla C, FordAlexander C, KhanKhurram J, MoayyediPaul, TalleyNicholas J, UllmanThomas A

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

The efficacy of immunosuppressive therapies (thiopurine analogs, methotrexate, and cyclosporine) in inducing remission and preventing relapse in inflammatory bowel disease (IBD) is being investigated through a systematic review of the literature.
Paper Details　
Original Abstract of the Article :
There remains controversy regarding the efficacy of thiopurine analogs (azathioprine (AZA) and 6-mercaptopurine (6-MP)), methotrexate (MTX), and cyclosporine for the treatment of inflammatory bowel disease (IBD). We performed an updated systematic review of the literature to clarify the efficacy of ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1038/ajg.2011.64

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Inflammatory Bowel Disease: A Quest for Effective Immunosuppressive Therapies

Immunosuppressive therapies are a critical tool in the fight against inflammatory bowel disease (IBD). This research delves into the effectiveness of various immunosuppressive medications, including thiopurine analogs (AZA and 6-MP), methotrexate (MTX), and cyclosporine, in treating IBD. Like a seasoned explorer, this study systematically reviews the literature to map out the efficacy of these therapies in inducing remission and preventing relapse in ulcerative colitis (UC) and Crohn's disease (CD). The authors navigated a vast landscape of research, analyzing data from numerous studies. Their findings provide valuable insights into the effectiveness of different immunosuppressive therapies.

A Beacon of Hope: Finding the Right Path for IBD Patients

The study's findings offer a glimmer of hope for those navigating the often-challenging terrain of IBD. By providing a comprehensive review of the effectiveness of various immunosuppressive therapies, the researchers have illuminated a path toward better treatment options. This research provides a roadmap for clinicians seeking to optimize treatment strategies for their patients.

Living with IBD: A Journey of Understanding and Management

IBD is a chronic condition, and understanding its nuances is crucial for managing its impact on daily life. This research highlights the importance of individualized treatment plans, tailored to the specific needs of each patient. A close collaboration between patients and their healthcare providers is essential for navigating the complexities of IBD management and maximizing treatment outcomes.

Dr. Camel's Conclusion

This research shines a light on the importance of choosing the right immunosuppressive therapy for patients with IBD. While there is no one-size-fits-all solution, this study offers a comprehensive guide for clinicians, helping them to navigate the vast and complex desert of IBD treatment options.
Date :
  1. Date Completed 2011-06-06
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

21407186

DOI: Digital Object Identifier

10.1038/ajg.2011.64

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.